Details of the Drug Formulations

General Information of Drug (ID: DMAHSU0)

Drug Name
Selexipag Drug Info
Synonyms
Selexipag; NS-304; 475086-01-2; Uptravi; NS 304; ACT-293987; UNII-5EXC0E384L; Selexipag(NS-304); ACT 293987; 5EXC0E384L; 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide; 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; 2-(4-((5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy}-n-(methanesulfonyl)acetamide; Selexipag [USAN:INN]; 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide; Uptravi (TN)
Indication
Disease Entry ICD 11 Status REF
Pulmonary arterial hypertension BB01.0 Approved [1]
Cross-matching ID
PubChem CID
9913767
ChEBI ID
CHEBI:90844
CAS Number
475086-01-2
TTD ID
D0N2SR
INTEDE ID
DR1471
ACDINA ID
D00619

Full List of Drug Formulations Containing This Drug

Selexipag 1.6 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19755 Magnesium stearate; Mannitol; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 0.6 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19750 Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 0.8 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19751 Magnesium stearate; Mannitol; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 1 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19752 Magnesium stearate; Mannitol; Ferric oxide red; Ferric oxide yellow; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 1.2 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19753 Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 0.2 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19748 Magnesium stearate; Mannitol; Ferric oxide yellow; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 0.4 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19749 Magnesium stearate; Mannitol; Ferric oxide red; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------
Selexipag 1.4 mg tablet
Company Formulation ID FDA Description
Actelion Pharmaceuticals US F19754 Magnesium stearate; Mannitol; Ferric oxide yellow; Propylene glycol; Titanium dioxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7552).